Engineered for DPP-IV resistance and extended half-life via C20 fatty diacid modification
The minimum safety window between tirzepatide injections is three days, or 72 hours
Hepatic lipotoxicity creates a pro-inflammatory environment that makes the liver highly susceptible to simultaneous insults, including mitochondrial dysfunction (generating oxidative stress), endoplasmic reticulum stress (Miller et al., 2025
Although uncommon, identifying these patterns early can guide dose adjustments or therapy changes when necessary
Most Common Uses Retatrutide, an investigational peptide, is gaining attention for its potential in treating metabolic disorders through its innovative triple-agonist mechanism, which simultaneously targets glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1) receptors